9724005

Source:http://linkedlifedata.com/resource/pubmed/id/9724005

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists.
Subject	Predicate	Object	Context
pubmed-article:9724005	rdf:type	pubmed:Citation	lld:pubmed
pubmed-article:9724005	lifeskim:mentions	umls-concept:C0016911	lld:lifeskim
pubmed-article:9724005	lifeskim:mentions	umls-concept:C0221198	lld:lifeskim
pubmed-article:9724005	lifeskim:mentions	umls-concept:C0178602	lld:lifeskim
pubmed-article:9724005	lifeskim:mentions	umls-concept:C0015219	lld:lifeskim
pubmed-article:9724005	lifeskim:mentions	umls-concept:C0024485	lld:lifeskim
pubmed-article:9724005	lifeskim:mentions	umls-concept:C1999177	lld:lifeskim
pubmed-article:9724005	pubmed:issue	2	lld:pubmed
pubmed-article:9724005	pubmed:dateCreated	1998-11-3	lld:pubmed
pubmed-article:9724005	pubmed:abstractText	To investigate the evolution of multiple sclerosis (MS) lesions enhancing after single dose (SD) or triple dose (TD) of gadolinium-DTPA (Gd).	lld:pubmed
pubmed-article:9724005	pubmed:language	eng	lld:pubmed
pubmed-article:9724005	pubmed:journal	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:9724005	pubmed:citationSubset	IM	lld:pubmed
pubmed-article:9724005	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:9724005	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:9724005	pubmed:status	MEDLINE	lld:pubmed
pubmed-article:9724005	pubmed:month	Aug	lld:pubmed
pubmed-article:9724005	pubmed:issn	0001-6314	lld:pubmed
pubmed-article:9724005	pubmed:author	pubmed-author:MastronardiMM	lld:pubmed
pubmed-article:9724005	pubmed:author	pubmed-author:GasperiniCC	lld:pubmed
pubmed-article:9724005	pubmed:author	pubmed-author:FilippiMM	lld:pubmed
pubmed-article:9724005	pubmed:author	pubmed-author:PrandiniFF	lld:pubmed
pubmed-article:9724005	pubmed:author	pubmed-author:RovarisMM	lld:pubmed
pubmed-article:9724005	pubmed:author	pubmed-author:YousryT ATA	lld:pubmed
pubmed-article:9724005	pubmed:issnType	Print	lld:pubmed
pubmed-article:9724005	pubmed:volume	98	lld:pubmed
pubmed-article:9724005	pubmed:owner	NLM	lld:pubmed
pubmed-article:9724005	pubmed:authorsComplete	Y	lld:pubmed
pubmed-article:9724005	pubmed:pagination	90-3	lld:pubmed
pubmed-article:9724005	pubmed:dateRevised	2006-11-15	lld:pubmed
pubmed-article:9724005	pubmed:meshHeading	pubmed-meshheading:9724005-...	lld:pubmed
pubmed-article:9724005	pubmed:meshHeading	pubmed-meshheading:9724005-...	lld:pubmed
pubmed-article:9724005	pubmed:meshHeading	pubmed-meshheading:9724005-...	lld:pubmed
pubmed-article:9724005	pubmed:meshHeading	pubmed-meshheading:9724005-...	lld:pubmed
pubmed-article:9724005	pubmed:meshHeading	pubmed-meshheading:9724005-...	lld:pubmed
pubmed-article:9724005	pubmed:meshHeading	pubmed-meshheading:9724005-...	lld:pubmed
pubmed-article:9724005	pubmed:meshHeading	pubmed-meshheading:9724005-...	lld:pubmed
pubmed-article:9724005	pubmed:meshHeading	pubmed-meshheading:9724005-...	lld:pubmed
pubmed-article:9724005	pubmed:meshHeading	pubmed-meshheading:9724005-...	lld:pubmed
pubmed-article:9724005	pubmed:year	1998	lld:pubmed
pubmed-article:9724005	pubmed:articleTitle	MRI evolution of new MS lesions enhancing after different doses of gadolinium.	lld:pubmed
pubmed-article:9724005	pubmed:affiliation	Neuroimaging Research Unit, IRCCS Ospedale San Raffaele, University of Milan, Italy.	lld:pubmed
pubmed-article:9724005	pubmed:publicationType	Journal Article	lld:pubmed
pubmed-article:9724005	pubmed:publicationType	Research Support, Non-U.S. Gov't	lld:pubmed